HBM Holdings Independent Director Faces CSRC Probe; Board Affirms Normal Operations

Bulletin Express

05/13

HBM Holdings Limited announced that independent non-executive director Dr. Xiaoping Ye received a case-filing notice from the China Securities Regulatory Commission on 12 May 2026. The investigation concerns alleged violations of information-disclosure rules related to changes in the shareholding of Hangzhou Tigermed Consulting Co., Ltd.

Dr. Ye holds no management responsibilities within HBM Holdings and will cooperate fully with regulators. The board stated that the Group’s daily operations remain unaffected and pledged to release further updates as required.

Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was signed by Chairman and Executive Director Dr. Jingsong Wang on 13 May 2026.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1143981327"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143981327\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143981327?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-13 12:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143981327","market":"us","top_or_hot":-1,"title":"HBM Holdings Independent Director Faces CSRC Probe; Board Affirms Normal Operations","media":"Bulletin Express","content":"<p>HBM Holdings Limited announced that independent non-executive director Dr. Xiaoping Ye received a case-filing notice from the China Securities Regulatory Commission on 12 May 2026. The investigation concerns alleged violations of information-disclosure rules related to changes in the shareholding of Hangzhou Tigermed Consulting Co., Ltd.</p>\n<p>Dr. Ye holds no management responsibilities within HBM Holdings and will cooperate fully with regulators. The board stated that the Group’s daily operations remain unaffected and pledged to release further updates as required.</p>\n<p>Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was signed by Chairman and Executive Director Dr. Jingsong Wang on 13 May 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HBM Holdings Independent Director Faces CSRC Probe; Board Affirms Normal Operations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHBM Holdings Independent Director Faces CSRC Probe; Board Affirms Normal Operations\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-05-13 12:23</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>HBM Holdings Limited announced that independent non-executive director Dr. Xiaoping Ye received a case-filing notice from the China Securities Regulatory Commission on 12 May 2026. The investigation concerns alleged violations of information-disclosure rules related to changes in the shareholding of Hangzhou Tigermed Consulting Co., Ltd.</p>\n<p>Dr. Ye holds no management responsibilities within HBM Holdings and will cooperate fully with regulators. The board stated that the Group’s daily operations remain unaffected and pledged to release further updates as required.</p>\n<p>Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was signed by Chairman and Executive Director Dr. Jingsong Wang on 13 May 2026.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02142","symbol_name":"和鉑醫藥-B","start_time":0,"source_url":"","article_id":"1143981327","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143981327","pubTimestamp":1778646188,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"HBM Holdings Limited announced that independent non-executive director Dr. Xiaoping Ye received a case-filing notice from the China Securities Regulatory Commission on 12 May 2026. The investigation...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02142":"和铂医药-B"},"translate_title":"HBM Holdings独立董事面临证监会调查；董事会确认运营正常","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02142":1},"content_text":"HBM Holdings Limited announced that independent non-executive director Dr. Xiaoping Ye received a case-filing notice from the China Securities Regulatory Commission on 12 May 2026. The investigation concerns alleged violations of information-disclosure rules related to changes in the shareholding of Hangzhou Tigermed Consulting Co., Ltd.\nDr. Ye holds no management responsibilities within HBM Holdings and will cooperate fully with regulators. The board stated that the Group’s daily operations remain unaffected and pledged to release further updates as required.\nShareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was signed by Chairman and Executive Director Dr. Jingsong Wang on 13 May 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}